Trial Profile
A treatment algorithm evaluating the effect of zoledronic acid on bone mineral density loss after allogeneic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2019
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 19 Jun 2017 Status changed from not yet recruiting to completed according to results published in the Bone Marrow Transplantation..
- 30 Jun 2016 New trial record